Abbott files and sells shelf periodically. Probably in the recent case to fund AMO.
Under the Obamanation there could still be large pharma M&A (amonst MRK, SGP, ABT, JNJ) in the offing. JNJ is probably being compelled to do something. Wall Street will generally label the winners and losers.
The start of the long hot summer is only about 10 weeks away.